FDA Approves First Treatment for Post-Partum Depression
The U.S. Food and Drug Administration today approved Sage Therapeutics compound Zulresso (brexanolone) injection for intravenous (IV) use for the ...
The U.S. Food and Drug Administration today approved Sage Therapeutics compound Zulresso (brexanolone) injection for intravenous (IV) use for the ...
© 2025 Higher Education Plus
Need Help